CPA
MEDP icon

Capital Performance Advisors’s Medpace MEDP Stock Holding History

Capital Performance Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-466
Closed -$224K – 422
2026
Q1 		$224K Sell
466
-335
-42% -$172K 0.02% 406
2025
Q4 		$450K Buy
801
+153
+24% +$86.8K 0.03% 234
2025
Q3 		$333K Buy
+648
New +$283K 0.05% 194
2025
Q1 		– Sell
-715
Closed -$238K – 275
2024
Q4 		$238K Buy
715
+578
+422% +$196K 0.08% 127
2024
Q3 		$45.7K Buy
+137
New +$52K 0.01% 369

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Performance Advisors's MEDP Position: Q2 2026 in Review

Capital Performance Advisors sold out of Medpace (MEDP) in Q2 2026, closing a stake of 466 shares — an estimated $224K sold.

Capital Performance Advisors first reported a position in MEDP in Q3 2024 and held it in 5 quarters. The position peaked at $450K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Capital Performance Advisors reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 466 Medpace shares in Q2 2026, an estimated $224K.
  • Capital Performance Advisors first reported a position in Medpace in Q3 2024 and held it in 5 quarters.
  • Capital Performance Advisors's Medpace position peaked at $450K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.